Equities Research Analysts’ Updated EPS Estimates for January 29th (ADT, ADT1, AGL, APLS, ARE, AX, AXSM, BA, BMRC, BUSE)

Equities Research Analysts’ updated eps estimates for Wednesday, January 29th:

ADT (NYSE:ADT) had its sector perform rating reiterated by analysts at Royal Bank of Canada. They currently have a $9.00 price target on the stock.

Adriatic Metals (LON:ADT1) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 220 ($2.74) price target on the stock.

ANGLE (LON:AGL) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a GBX 40 ($0.50) target price on the stock.

Apellis Pharmaceuticals (NASDAQ:APLS) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $26.00 target price on the stock.

Alexandria Real Estate Equities (NYSE:ARE) had its market outperform rating reissued by analysts at JMP Securities. JMP Securities currently has a $130.00 price target on the stock.

Axos Financial (NYSE:AX) had its outperform rating reiterated by analysts at Raymond James. Raymond James currently has a $80.00 price target on the stock, up from their previous price target of $75.00.

Axsome Therapeutics (NASDAQ:AXSM) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $139.00 price target on the stock.

Boeing (NYSE:BA) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $200.00 price target on the stock.

Bank of Marin Bancorp (NASDAQ:BMRC) had its overweight rating reiterated by analysts at Stephens. The firm currently has a $30.00 price target on the stock.

First Busey (NASDAQ:BUSE) had its equal weight rating reaffirmed by analysts at Stephens. The firm currently has a $29.00 target price on the stock.

Camden National (NASDAQ:CAC) had its outperform rating reissued by analysts at Raymond James. They currently have a $53.00 price target on the stock, up from their previous price target of $50.00.

Chubb (NYSE:CB) had its market outperform rating reaffirmed by analysts at JMP Securities. They currently have a $325.00 target price on the stock.

Coastal Financial (NASDAQ:CCB) had its strong-buy rating reiterated by analysts at Raymond James. They currently have a $100.00 target price on the stock, up from their previous target price of $88.00.

Citizens Financial Group (NYSE:CFG) had its overweight rating reaffirmed by analysts at Stephens. They currently have a $53.00 price target on the stock.

Colgate-Palmolive (NYSE:CL) had its sector perform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $101.00 target price on the stock.

Celldex Therapeutics (NASDAQ:CLDX) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $67.00 price target on the stock.

Cimpress (NASDAQ:CMPR) had its outperform rating reissued by analysts at Barrington Research. They currently have a $119.00 target price on the stock.

Capri (NYSE:CPRI) had its market perform rating reaffirmed by analysts at Telsey Advisory Group. They currently have a $23.00 price target on the stock.

CoStar Group (NASDAQ:CSGP) had its overweight rating reissued by analysts at Stephens. They currently have a $103.00 target price on the stock.

Commvault Systems (NASDAQ:CVLT) had its neutral rating reaffirmed by analysts at Guggenheim.

Ceres Power (LON:CWR) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 650 ($8.09) price target on the stock.

DHI Group (NYSE:DHX) had its outperform rating reaffirmed by analysts at Barrington Research. They currently have a $7.00 price target on the stock.

Dun & Bradstreet (NYSE:DNB) had its sector perform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $12.00 target price on the stock.

Dynatrace (NYSE:DT) had its buy rating reissued by analysts at Rosenblatt Securities. The firm currently has a $65.00 target price on the stock.

Enterprise Financial Services (NASDAQ:EFSC) had its outperform rating reaffirmed by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $70.00 price target on the stock, up from their previous price target of $68.00.

Elevance Health (NYSE:ELV) had its hold rating reissued by analysts at Argus. They currently have a $405.40 target price on the stock.

First Commonwealth Financial (NYSE:FCF) had its overweight rating reiterated by analysts at Stephens. They currently have a $21.50 target price on the stock.

Paragon 28 (NYSE:FNA) had its hold rating reaffirmed by analysts at Needham & Company LLC. They currently have a $13.00 price target on the stock.

Five Star Bancorp (NASDAQ:FSBC) had its outperform rating reiterated by analysts at Raymond James. The firm currently has a $35.00 price target on the stock, down from their previous price target of $38.00.

GDS (NASDAQ:GDS) had its outperform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $26.00 target price on the stock.

HIVE Digital Technologies (NASDAQ:HIVE) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $8.00 target price on the stock.

Houlihan Lokey (NYSE:HLI) had its market perform rating reaffirmed by analysts at JMP Securities.

Houlihan Lokey (NYSE:HLI) had its market perform rating reissued by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $192.00 price target on the stock, up from their previous price target of $170.00.

Invesco (NYSE:IVZ) had its market perform rating reaffirmed by analysts at Keefe, Bruyette & Woods. The firm currently has a $20.00 target price on the stock, up from their previous target price of $18.00.

Kimberly-Clark (NYSE:KMB) had its overweight rating reissued by analysts at Piper Sandler. Piper Sandler currently has a $158.00 target price on the stock, down from their previous target price of $161.00.

LendingClub (NYSE:LC) had its outperform rating reissued by analysts at Keefe, Bruyette & Woods. They currently have a $16.00 price target on the stock, down from their previous price target of $17.00.

LendingClub (NYSE:LC) had its overweight rating reissued by analysts at Piper Sandler. Piper Sandler currently has a $19.00 price target on the stock, down from their previous price target of $20.00.

Littelfuse (NASDAQ:LFUS) had its hold rating reiterated by analysts at Benchmark Co..

Lexicon Pharmaceuticals (NASDAQ:LXRX) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $4.00 target price on the stock.

Lexicon Pharmaceuticals (NASDAQ:LXRX) had its hold rating reiterated by analysts at Needham & Company LLC.

Manhattan Associates (NASDAQ:MANH) had its overweight rating reissued by analysts at Piper Sandler. The firm currently has a $268.00 price target on the stock, down from their previous price target of $326.00.

Meta Platforms (NASDAQ:META) had its hold rating reaffirmed by analysts at Benchmark Co..

Merit Medical Systems (NASDAQ:MMSI) had its overweight rating reaffirmed by analysts at Piper Sandler. They currently have a $116.00 target price on the stock, up from their previous target price of $114.00.

Microsoft (NASDAQ:MSFT) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $509.00 target price on the stock.

Nextracker (NASDAQ:NXT) had its outperform rating reiterated by analysts at Northland Securities. The firm currently has a $55.00 target price on the stock, up from their previous target price of $48.00.

Nextracker (NASDAQ:NXT) had its buy rating reiterated by analysts at Truist Financial Co.. They currently have a $56.00 price target on the stock, up from their previous price target of $54.00.

Origin Bancorp (NASDAQ:OBK) had its outperform rating reaffirmed by analysts at Keefe, Bruyette & Woods. They currently have a $45.00 price target on the stock, up from their previous price target of $42.00.

Opthea (NASDAQ:OPT) had its buy rating reissued by analysts at HC Wainwright. They currently have a $12.00 target price on the stock.

PepsiCo (NASDAQ:PEP) had its sector perform rating reaffirmed by analysts at Royal Bank of Canada. They currently have a $172.00 price target on the stock.

Phreesia (NYSE:PHR) had its overweight rating reiterated by analysts at Piper Sandler. Piper Sandler currently has a $33.00 target price on the stock, up from their previous target price of $31.00.

Park National (NYSE:PRK) had its market perform rating reaffirmed by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $178.00 target price on the stock, down from their previous target price of $187.00.

Qorvo (NASDAQ:QRVO) had its hold rating reissued by analysts at Benchmark Co..

Qorvo (NASDAQ:QRVO) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $100.00 target price on the stock.

SAB Biotherapeutics (NASDAQ:SABS) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $6.00 price target on the stock.

SAB Biotherapeutics (NASDAQ:SABS) had its buy rating reiterated by analysts at Chardan Capital. They currently have a $25.00 target price on the stock.

Seacoast Banking Co. of Florida (NASDAQ:SBCF) had its outperform rating reiterated by analysts at Raymond James. They currently have a $31.00 target price on the stock, up from their previous target price of $29.00.

Skechers U.S.A. (NYSE:SKX) had its hold rating reaffirmed by analysts at Needham & Company LLC.

Stryker (NYSE:SYK) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $442.00 target price on the stock.

Synaptics (NASDAQ:SYNA) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $90.00 price target on the stock.

Sysco (NYSE:SYY) had its buy rating reiterated by analysts at Guggenheim. Guggenheim currently has a $85.00 price target on the stock.

Texas Capital Bancshares (NASDAQ:TCBI) had its outperform rating reissued by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $95.00 target price on the stock, down from their previous target price of $100.00.

Tracsis (LON:TRCS) had its buy rating reaffirmed by analysts at Berenberg Bank. The firm currently has a GBX 1,150 ($14.31) price target on the stock.

Transcat (NASDAQ:TRNS) had its market perform rating reissued by analysts at Northland Securities. Northland Securities currently has a $85.00 price target on the stock, down from their previous price target of $110.00.

Tesla (NASDAQ:TSLA) had its sell rating reiterated by analysts at Guggenheim. The firm currently has a $175.00 target price on the stock.

Tesla (NASDAQ:TSLA) had its neutral rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $365.00 target price on the stock.

Unicycive Therapeutics (NASDAQ:UNCY) had its buy rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $4.00 price target on the stock.

Usio (NASDAQ:USIO) had its buy rating reissued by analysts at HC Wainwright. They currently have a $4.00 target price on the stock.

VF (NYSE:VFC) had its market perform rating reaffirmed by analysts at Telsey Advisory Group. Telsey Advisory Group currently has a $21.00 price target on the stock.

VolitionRx (NYSE:VNRX) had its buy rating reiterated by analysts at D. Boral Capital. They currently have a $5.00 price target on the stock.

Zimmer Biomet (NYSE:ZBH) had its hold rating reaffirmed by analysts at Needham & Company LLC.